Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Induction Therapy for Palmoplantar Psoriasis
NCT00686686Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2007
- Primary completion
- Feb 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in palmoplantar psoriasis, sponsored by Merck & Co.. Started Dec 2007; status: completed.
02
Drugs
infliximab
03
Conditions
palmoplantar psoriasis
Beyond the preview
Go deeper on NCT00686686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686686.